Colon Cancer
Colon Cancer News and Colon Cancer Information.

The Earlier Rectal Cancer is Diagnosed, the Better the Cure Rate - KFSM.com
DEAR MAYO CLINIC: I have just been diagnosed with early stage rectal cancer and I’m only 40 years old. Am I going to have to wear a colostomy bag for the rest of my life? What are the statistics for this cancer? ANSWER: Rectal cancer, a form of colon

Keryx Reports Positive Data from Phase 2 Combination Study of KRX-0401 - RTT News
(RTTNews) - Keryx Biopharmaceuticals Inc. (KERX: News ) announced data on the clinical activity of KRX-0401 (perifosine), the Company’s Akt-inhibitor for cancer, in combination with capecitabine as a treatment for advanced colon cancer. The primary

AEterna Zentaris Partner Keryx Reports Positive Phase 2 Data for - Investors Business Daily
QUEBEC CITY, June 1, 2009 /PRNewswire-FirstCall via COMTEX/ — Data demonstrates perifosine’s anti-cancer activity and efficacy both as a single agent and in combination therapy AEterna Zentaris Inc. (AEZ)( AEZS ), a global biopharmaceutical company

Cancer fundraiser held in Sullivan - Times Herald-Record
LOCH SHELDRAKE Ask Pat Gibson her age and she will proudly proclaim it. “I’m 66 years old, and I’m proud of my 66 years,” she said Saturday at the Sullivan County Relay For Life, the American Cancer Society’s annual fundraiser, held at Sullivan

Local attorney battling cancer - Neosho Daily News
He never thought of himself as a cancer survivor. Six years ago, Andy Wood was diagnosed with colon cancer. Because the cancer was contained, he never underwent chemotherapy. With his treatment it could have been colitis, but they called it cancer

Genentech Announces Full Results from First Phase III Study of Avastin - Phramalive.com
– Study Does Not Meet Endpoint; However, Results Suggest Future Trials May Hold Promise for Avastin as Adjuvant Colon Cancer Treatment — ORLANDO, Fla.–(BUSINESS WIRE)–May 30, 2009 - Genentech, Inc. today announced results from a Phase III study

Keryx Biopharma Reveals Positive Data From Phase II Advanced - RTT News
(RTTNews) - Keryx Biopharmaceuticals Inc. (KERX: News ) Monday announced positive data from a phase II study, indicating that its Akt-inhibitor for cancer, perifosine in combination with capecitabine more than doubled time to progression and overall

AEterna Zentaris Partner Keryx Reports Positive Phase 2 Data for - Investors Business Daily
QUEBEC CITY, June 1, 2009 /PRNewswire-FirstCall via COMTEX/ — Data demonstrates perifosine’s anti-cancer activity and efficacy both as a single agent and in combination therapy AEterna Zentaris Inc. (AEZ)( AEZS ), a global biopharmaceutical company

Cancer fundraiser held in Sullivan - Times Herald-Record
LOCH SHELDRAKE Ask Pat Gibson her age and she will proudly proclaim it. “I’m 66 years old, and I’m proud of my 66 years,” she said Saturday at the Sullivan County Relay For Life, the American Cancer Society’s annual fundraiser, held at Sullivan

Chemo Alone Is Best for Advanced Colon Cancer - BusinessWeek
SATURDAY, May 30 (HealthDay News) –Surgery is no longer the best treatment option for most patients with advanced colorectal cancer that has spread to other organs, a new study suggests. Immediate colon resection (surgical removal) following

UCF, MD Anderson researchers working on over-the-counter test for - Orlando Sentinel
Diabetics test their blood-sugar levels by pricking a finger. Now a team of Orlando researchers are working on what could become a similar, over-the-counter test kit for prostate cancer. Qun Huo, an associate professor at the University of Central

Local attorney battling cancer - Neosho Daily News
He never thought of himself as a cancer survivor. Six years ago, Andy Wood was diagnosed with colon cancer. Because the cancer was contained, he never underwent chemotherapy. With his treatment it could have been colitis, but they called it cancer

Avastin Shows No Benefit Against Early Stage Colon Cancer - BusinessWeek
SATURDAY, May 30 (HealthDay News) — The cancer drug Avastin, widely used for lung, breast and metastatic colorectal cancers, appears ineffective for patients with early stage colon cancer, a result the trial’s lead author called “disappointing

Avastin Shows No Benefit Against Early Stage Colon Cancer - BusinessWeek
SATURDAY, May 30 (HealthDay News) — The cancer drug Avastin, widely used for lung, breast and metastatic colorectal cancers, appears ineffective for patients with early stage colon cancer, a result the trial’s lead author called “disappointing

Surgery Not Necessary For Most Late-stage Colorectal Cancers, Study - Science Daily
ScienceDaily (June 2, 2009) A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don’t require immediate surgery to remove the primary tumor in the colon

UCF, MD Anderson researchers working on over-the-counter test for - Orlando Sentinel
Diabetics test their blood-sugar levels by pricking a finger. Now a team of Orlando researchers are working on what could become a similar, over-the-counter test kit for prostate cancer. Qun Huo, an associate professor at the University of Central

Surgery not neccessary for most late-stage colorectal cancers - Food Consumer
Saturday May 30,2009 (foodconsumer.org) — A new study presented today at the American Society of Clinical Oncology Annual Meeting has found that surgery to remove most late-stage colorectal cancers may not be neccessary. Researchers from Memorial

Doctors: Early detection is best bet to battle cancer - Lake City Reporter
Early detection of cancer always leads to improved results, said Dr. Mark Thompson of North Florida Cancer Center of Lake City and Florida Radiation Oncology Group. Today is National Cancer Survivors Day, and two local doctors answered

Effective over-the-counter prostate cancer test kit likely in next few - PhysOrg
An over-the-counter prostate cancer test kit could be coming to a pharmacy near you, thanks to the collaborative work of a University of Central Florida chemist and M.D. Anderson Cancer Center Orlando researchers. UCF’s Qun “Treen” Huo and M.D

Sixty percent of cancer patients try nontraditional med - Chippewa Herald
TAMPA, Fla. With much of her lower body consumed by cancer, Leslee Flasch finally faced the truth: The herbal supplements and special diet were not working. “I want this thing cut out from me. I want it out,” she told her family. But it was too

Avastin Shows No Benefit Against Early Stage Colon Cancer - KVIA.com
SATURDAY, May 30 (HealthDay News) — The cancer drug Avastin, widely used for lung, breast and metastatic colorectal cancers, appears ineffective for patients with early stage colon cancer, a result the trial’s lead author called “disappointing

Surgery not neccessary for most late-stage colorectal cancers - Food Consumer
Saturday May 30,2009 (foodconsumer.org) — A new study presented today at the American Society of Clinical Oncology Annual Meeting has found that surgery to remove most late-stage colorectal cancers may not be neccessary. Researchers from Memorial

Chemo Alone Is Best for Advanced Colon Cancer - Forbes
SATURDAY, May 30 (HealthDay News) –Surgery is no longer the best treatment option for most patients with advanced colorectal cancer that has spread to other organs, a new study suggests. Immediate colon resection (surgical removal) following

Avastin Shows No Benefit Against Early Stage Colon Cancer - Forbes
SATURDAY, May 30 (HealthDay News) — The cancer drug Avastin, widely used for lung, breast and metastatic colorectal cancers, appears ineffective for patients with early stage colon cancer, a result the trial’s lead author called “disappointing

Surgery not necessary for most late-stage colorectal cancers - Genetic Engineering News
A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don’t require immediate surgery to remove the primary tumor in the colon. Researchers from Memorial Sloan

Surgery not neccessary for most late-stage colorectal cancers - Food Consumer
Saturday May 30,2009 (foodconsumer.org) — A new study presented today at the American Society of Clinical Oncology Annual Meeting has found that surgery to remove most late-stage colorectal cancers may not be neccessary. Researchers from Memorial

Keryx Biopharma Reveals Positive Data From Phase II Advanced - RTT News
(RTTNews) - Keryx Biopharmaceuticals Inc. (KERX: News ) Monday announced positive data from a phase II study, indicating that its Akt-inhibitor for cancer, perifosine in combination with capecitabine more than doubled time to progression and overall

Chemotherapy Combo Outcomes Differ For Colon Cancer Patients - eMaxHealth.com
The combination of chemotherapies 5FU and oxaliplatin compared to 5FU alone after surgery for colon cancer decreases colon cancer recurrence and promotes longer survival for patients under 70 but not for those who are older, according to Mayo

Freeman reporter Schweitzer dies at 44 after battling cancer - Daily Freeman
KINGSTON Blaise Schweitzer, a reporter for the Freeman since 1987, died on Friday at Benedictine Hospital. He was 44. Schweitzer was diagnosed with colon cancer in October 2008 and chronicled his battle against the disease in a weekly column that

Surgery nixed for advanced colon cancer - United Press International
NEW YORK, June 1 (UPI) — A majority of patients with advanced colorectal cancer that has spread to other organs may skip surgery and begin chemotherapy, U.S. researchers say. Lead author Philip Paty says the conventional approach to treating stage

No Benefit From Surgery for Metastatic Colon Cancer - ABC News
Surgeons who plan to operate to remove the original tumors from patients with metastatic colon cancer might do well to put down their scalpels and rely on chemotherapy instead, according to a new study. Patients with metastatic colon cancer should

Cancer Treatment For Any Size - Denver Channel
BACKGROUND: In traditional radiation therapy for cancer treatment, a patient is exposed to X-rays. As they pass through both healthy and cancerous tissue, X-rays leave a path of damage. It helps destroy tumors but also may cause damage to the

Genentech Announces Full Results from First Phase III Study of Avastin - Phramalive.com
– Study Does Not Meet Endpoint; However, Results Suggest Future Trials May Hold Promise for Avastin as Adjuvant Colon Cancer Treatment — ORLANDO, Fla.–(BUSINESS WIRE)–May 30, 2009 - Genentech, Inc. today announced results from a Phase III study

Keryx Reports Positive Data from Phase 2 Combination Study of KRX-0401 - RTT News
(RTTNews) - Keryx Biopharmaceuticals Inc. (KERX: News ) announced data on the clinical activity of KRX-0401 (perifosine), the Company’s Akt-inhibitor for cancer, in combination with capecitabine as a treatment for advanced colon cancer. The primary

Curtailing Skin Toxicity Associated With Colon Cancer Drug - eMaxHealth.com
With a pre-emptive, prophylactic skin regimen, patients who receive panitumumab for treatment of metastatic colorectal cancer may be able to avoid some of the skin-associated toxicities, according to data being presented at the 2009 ASCO Annual in

Avastin Shows No Benefit Against Early Stage Colon Cancer - Forbes
SATURDAY, May 30 (HealthDay News) — The cancer drug Avastin, widely used for lung, breast and metastatic colorectal cancers, appears ineffective for patients with early stage colon cancer, a result the trial’s lead author called “disappointing

Chemotherapy Combo Outcomes Differ For Colon Cancer Patients - eMaxHealth.com
The combination of chemotherapies 5FU and oxaliplatin compared to 5FU alone after surgery for colon cancer decreases colon cancer recurrence and promotes longer survival for patients under 70 but not for those who are older, according to Mayo

The Total Colon Cancer Diet - New London Day
Eating for success. Let me state unequivocally that I am a very successful eater in terms of consumption, calories and weight (gain). I tried out for the Olympic eating team but was declared a professional and not allowed to compete. Nathan s

No Benefit From Surgery for Metastatic Colon Cancer - ABC News
Surgeons who plan to operate to remove the original tumors from patients with metastatic colon cancer might do well to put down their scalpels and rely on chemotherapy instead, according to a new study. Patients with metastatic colon cancer should

Age Of Colon Cancer Patients Affects Chemotherapy Combination Outcomes - Medical News Today
The combination of chemotherapies 5FU and oxaliplatin compared to 5FU alone after surgery for colon cancer decreases colon cancer recurrence and promotes longer survival for patients under 70 — but not for those who are older, according to Mayo

Surgery nixed for advanced colon cancer - United Press International
NEW YORK, June 1 (UPI) — A majority of patients with advanced colorectal cancer that has spread to other organs may skip surgery and begin chemotherapy, U.S. researchers say. Lead author Philip Paty says the conventional approach to treating stage

Chemo Alone Is Best for Advanced Colon Cancer - Forbes
SATURDAY, May 30 (HealthDay News) –Surgery is no longer the best treatment option for most patients with advanced colorectal cancer that has spread to other organs, a new study suggests. Immediate colon resection (surgical removal) following

Worth of Sigmoidoscopy Screening for Colon Cancer Still Uncertain - Austin American-Statesman
MONDAY, June 1 (HealthDay News) — Patients checked for colon cancer with a procedure called flexible sigmoidoscopy showed no significant reduction in risk over seven years, but the screening did seem to lower the risk of dying from the disease

The Total Colon Cancer Diet - New London Day
Eating for success. Let me state unequivocally that I am a very successful eater in terms of consumption, calories and weight (gain). I tried out for the Olympic eating team but was declared a professional and not allowed to compete. Nathan s

Avastin Shows No Benefit Against Early Stage Colon Cancer - Forbes
SATURDAY, May 30 (HealthDay News) — The cancer drug Avastin, widely used for lung, breast and metastatic colorectal cancers, appears ineffective for patients with early stage colon cancer, a result the trial’s lead author called “disappointing